Aptar Pharma wins CE marking for LuerVax intranasal vaccine device
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 128.10 +2.47 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.63 | 52 Week High | $81.50 | |||
| Open | $125.66 | 52 Week Low | $66.33 | |||
| Day High | $128.72 | P/E | 50.83 | |||
| Day Low | $124.83 | EPS | $2.52 | |||
| Volume | 426,359 | |||||
